Dosing recommendations in liver disease

Clinical Pharmacology and Therapeutics

Volumn 66, Issue 2, 1999, Pages 201-204

  Bergquist, C ^a   Lindegard, J ^a   Salmonson, T ^a  

^a MEDICAL PRODUCTS AGENCY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; LANSOPRAZOLE; SERUM ALBUMIN;

AREA UNDER THE CURVE; CONTROLLED STUDY; DOSE LIVER FUNCTION RELATION; DRUG METABOLISM; HUMAN; LETTER; LIVER CIRRHOSIS; LIVER DISEASE; PRIORITY JOURNAL; URINARY EXCRETION;

AREA UNDER CURVE; BILIRUBIN; HUMANS; LINEAR MODELS; LIVER DISEASES; PHARMACOKINETICS; PILOT PROJECTS; PROTHROMBIN TIME; SERUM ALBUMIN; SWEDEN;

EID: 0032795430     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(99)90058-9     Document Type: Letter

References (1)